Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/OPX.0000000000001747 http://scihub22266oqcxt.onion/10.1097/OPX.0000000000001747 34460447!ä!34460447 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Optom+Vis+Sci 2021 ; 98 (8): 867-869 Nephropedia Template TP {{tp|p=34460447|t=2021. Case Report: Steroid-induced Ocular Hypertension in a 6-year-old Boy |pdf=|usr=}}{{34460447}} gab.com Text Case Report: Steroid-induced Ocular Hypertension in a 6-year-old Boy JO: Optom Vis Sci http://www.kidney.de/pget.php?&tw=1&pmid=34460447 #FOAvip SIGNIFICANCE: Systemic corticosteroid use in children is rare because of known risks of adverse effects. The increased prevalence of multisystem inflammatory syndrome associated with COVID-19 may change this. It is critical for eye care providers to be aware of potential severe and rapid ocular hypertensive response to prevent irreversible vision loss. PURPOSE: The purpose of this study was to report the importance of early monitoring of intraocular eye pressure in pediatric patients on systemic steroid medication. CASE REPORT: A 6-year-old White boy presented with a complaint of headache for 2 weeks. He was on his 19th day of treatment for acute lymphoblastic leukemia with oral dexamethasone and chemotherapy. IOP at presentation was 65 mmHg in both eyes measured with iCare tonometry. Treatment with maximum topical glaucoma therapy reduced IOP to normal levels and eliminated the symptom of headache. CONCLUSIONS: This case reminds eye care providers to be aware of the potential ocular hypertensive response to systemic steroid treatment and the importance of establishing early monitoring. With the emergence of multisystem inflammatory syndrome in children during the current COVID-19 pandemic, eye care providers may encounter more pediatric patients on systemic corticosteroid treatment than previously and should adjust their examinations appropriately. Twit Text FOAVip Case Report: Steroid-induced Ocular Hypertension in a 6-year-old Boy ????Optom Vis Sci http://www.kidney.de/pget.php?&tw=1&pmid=34460447 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34460447 #FOAvip English Wikipedia <ref>{{Cite pmid|34460447}}</ref> Case Report: Steroid-induced Ocular Hypertension in a 6-year-old Boy #MMPMID34460447 Tasaki A Optom Vis Sci 2021[Aug]; 98 (8): 867-869 PMID34460447show ga SIGNIFICANCE: Systemic corticosteroid use in children is rare because of known risks of adverse effects. The increased prevalence of multisystem inflammatory syndrome associated with COVID-19 may change this. It is critical for eye care providers to be aware of potential severe and rapid ocular hypertensive response to prevent irreversible vision loss. PURPOSE: The purpose of this study was to report the importance of early monitoring of intraocular eye pressure in pediatric patients on systemic steroid medication. CASE REPORT: A 6-year-old White boy presented with a complaint of headache for 2 weeks. He was on his 19th day of treatment for acute lymphoblastic leukemia with oral dexamethasone and chemotherapy. IOP at presentation was 65 mmHg in both eyes measured with iCare tonometry. Treatment with maximum topical glaucoma therapy reduced IOP to normal levels and eliminated the symptom of headache. CONCLUSIONS: This case reminds eye care providers to be aware of the potential ocular hypertensive response to systemic steroid treatment and the importance of establishing early monitoring. With the emergence of multisystem inflammatory syndrome in children during the current COVID-19 pandemic, eye care providers may encounter more pediatric patients on systemic corticosteroid treatment than previously and should adjust their examinations appropriately. |*COVID-19[MESH] |*Glaucoma/chemically induced/diagnosis/drug therapy[MESH] |*Ocular Hypertension/chemically induced/diagnosis[MESH] |Child[MESH] |Humans[MESH] |Intraocular Pressure[MESH] |Male[MESH] |Pandemics[MESH] |SARS-CoV-2[MESH] |Steroids[MESH] |Systemic Inflammatory Response Syndrome[MESH]Case Report: Steroid-induced Ocular Hypertension in a 6-year-old Boy (epmc).pdf DeepDyve Pubget Overpricing